Prostanoids influence differentiation in diverse cell types. Altered expression of cyclooxygenase and prostaglandins has been implicated in the pathophysiology of placental dysfunction, which results in preeclampsia and fetal growth restriction. We hypothesized that prostanoids modulate differentiation and apoptosis in cultured human trophoblasts. Villous cytotrophoblasts were isolated from term human placentas and cultured in serumfree medium. The level of human chorionic gonadotropin was used as a marker of biochemical differentiation of primary trophoblasts, and syncytia formation was used as a marker of morphologic differentiation. Of the prostanoids tested, we found exposure to thromboxane A 2 hindered both biochemical and morphologic differentiation of cultured trophoblasts. As expected, human chorionic gonadotropin levels in the media were elevated in a concentration-dependent manner in the presence of the thromboxane synthase inhibitor, sodium furegrelate, or the thromboxane A 2 receptor blocker SQ 29,548. Furthermore, thromboxane A 2 enhanced trophoblast apoptosis, determined using terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining, cell morphology, and a concentrationdependent increase in p53 expression. We conclude that thromboxane A 2 hinders differentiation and enhances apoptosis in cultured trophoblasts from term human placenta. We speculate that thromboxane may contribute to placental dysfunction by restricting differentiation and enhancing apoptosis in human trophoblasts. The function of the human placenta depends on multinucleated, terminally differentiated syncytiotrophoblasts. This epithelium is in direct contact with maternal blood and regulates maternal-fetal exchange of micronutrients and gases. The syncytiotrophoblast arises from fusion of relatively undifferentiated, mitotically active cytotrophoblasts. This process involves morphologic and biochemical differentiation. Morphologic differentiation is defined by fusion of mononucleated cytotrophoblasts with adjacent syncytium (1). Biochemical differentiation is characterized by production of hormones such as hCG and human placental lactogen (2-4). Preeclampsia and FGR are associated with trophoblast hypoxia and placental dysfunction (5). Villi from women with these conditions typically exhibit diminished villus formation, prominent cytotrophoblasts, enhanced syncytial knot formation, and apoptosis (6, 7). An increase in TX synthesis has been demonstrated in villi (8, 9) and trophoblasts (10, 11) from preeclamptic women compared with healthy control subjects. Importantly, FGR (12) and preeclampsia (13) are associated with elevated TXA 2 levels in the circulation of pregnant women. Although the effect of prostanoids on vascular reactivity is well known (14), recent studies indicate that prostanoids also regulate proliferation, differentiation, and apoptosis in many cell types (15-18). We tested the hypothesis that prostanoids influence the differentiation of cultured trophoblasts from term human placenta. We found that TXA 2 hinders both morphologic and biochemical differentiation and enhances apoptosis in primary human trophoblasts.
thromboxane A 2 enhanced trophoblast apoptosis, determined using terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining, cell morphology, and a concentrationdependent increase in p53 expression. We conclude that thromboxane A 2 hinders differentiation and enhances apoptosis in cultured trophoblasts from term human placenta. We speculate that thromboxane may contribute to placental dysfunction by restricting differentiation and enhancing apoptosis in human trophoblasts. The function of the human placenta depends on multinucleated, terminally differentiated syncytiotrophoblasts. This epithelium is in direct contact with maternal blood and regulates maternal-fetal exchange of micronutrients and gases. The syncytiotrophoblast arises from fusion of relatively undifferentiated, mitotically active cytotrophoblasts. This process involves morphologic and biochemical differentiation. Morphologic differentiation is defined by fusion of mononucleated cytotrophoblasts with adjacent syncytium (1) . Biochemical differentiation is characterized by production of hormones such as hCG and human placental lactogen (2) (3) (4) . Preeclampsia and FGR are associated with trophoblast hypoxia and placental dysfunction (5) . Villi from women with these conditions typically exhibit diminished villus formation, prominent cytotrophoblasts, enhanced syncytial knot formation, and apoptosis (6, 7) . An increase in TX synthesis has been demonstrated in villi (8, 9) and trophoblasts (10, 11) from preeclamptic women compared with healthy control subjects. Importantly, FGR (12) and preeclampsia (13) are associated with elevated TXA 2 levels in the circulation of pregnant women. Although the effect of prostanoids on vascular reactivity is well known (14) , recent studies indicate that prostanoids also regulate proliferation, differentiation, and apoptosis in many cell types (15) (16) (17) (18) . We tested the hypothesis that prostanoids influence the differentiation of cultured trophoblasts from term human placenta. We found that TXA 2 hinders both morphologic and biochemical differentiation and enhances apoptosis in primary human trophoblasts.
METHODS
Cell isolation and culture. The study was approved by the Human Studies Committee of Washington University. Placen-tas were obtained immediately after term singleton deliveries after uncomplicated pregnancies. Cytotrophoblasts were isolated by the trypsin-DNase, Percoll (Pharmacia, Piscataway, NJ, U.S.A.) gradient centrifugation method described by Kliman et al. (2) instructions. Using bright-field optics at 1000ϫ, two observers blinded to culture conditions quantified TUNEL-stained nuclei as well as the number of total nuclei in eight random fields. The apoptotic index was defined as the percentage of TUNELpositive nuclei divided by the total number of nuclei. Cells exposed to vehicle alone served as control, and omission of the terminal deoxynucleotidyl transferase step served as a staining control.
In a tandem analysis, we examined cells for morphologic changes typical for apoptosis, including condensed or fragmented nuclei, a low cytoplasm to nucleus ratio (indicative of cell shrinkage), and blebbing of the surface membrane. Cells with apoptotic morphology were expressed as a percentage of the total number of cells counted.
Western blot. Cells were collected in a lysis buffer that contained 10% SDS and were sonicated. Samples with equal amounts of protein (30 g) were subjected to electrophoresis at 60 V for 2 h in 4°C using 10% polyacrylamide gel slabs, then transferred overnight to polyvinylidene difluoride membranes. Membranes were incubated with 10% skim milk for 1 h, incubated with an anti-p53 MAb (Santa Cruz Biochemicals, Santa Cruz, CA, U.S.A.) for 1 h, washed twice for 10 min with Tris-buffered saline (TBS; 0.75% Tween 20), and then incubated for 1 h with horseradish-peroxidase-linked secondary antibodies (Santa Cruz). The membrane was washed twice for 10 min with TBS, processed for chemiluminescence using an enhanced chemiluminescence kit (Amersham, Pharmacia Biotech, Piscataway, NJ, U.S.A.), and exposed to film for 10 min. Cells exposed to vehicle alone served as controls. The density of the immunoblot bands was quantified using a densitometer and Image Quant version 3.3 software (Molecular Dynamics, Sunnyvale, CA, U.S.A.).
Statistical analysis. Each measurement was performed in duplicate for each paradigm. Data are presented as mean Ϯ SD. Comparisons were made using t test and ANOVA with Bonferroni correction where applicable. A p Ͻ 0.05 was considered significant.
RESULTS

Influence of prostanoids on trophoblast differentiation.
We initially screened the effect of nine prostanoids on media levels of hCG during a 72-h culture period. These prostanoids were selected because they are known to affect differentiation, apoptosis, or proliferation of nontrophoblast cells (23-27). We used 15-deoxy-⌬ 12,14 -PGJ 2 , known to hinder differentiation and enhance apoptosis, as a positive control (28). Because of the short half-life of TXA 2 (32 s), we used a stable analog of TXA 2 , carbocyclic TXA 2 , for our experiments (29). Among the prostanoids tested, exposure of cultured trophoblasts to TXA 2 resulted in a significant reduction in hCG release compared with control cells (Fig. 1A) . The effect of TXA 2 on medium hCG was concentration dependent, with a maximum effect at 10 M (Fig. 1B) , and the effect was apparent in the absence or presence of serum. This result indicates that exposure of trophoblasts to exogenous TXA 2 hinders their biochemical differentiation.
To determine whether endogenous TXA 2 has a similar effect, we determined the effect of either a TX synthase inhibitor or a TX receptor blocker on hCG production. We predicted that addition of either of these agents would result in higher media levels of hCG. We first determined the time course for production of TX by trophoblasts in serum-free media, and found that TX levels were highest in the first 12 h of culture ( Fig. 2A) . Similar results were obtained using serumcontaining media. The production of TXA 2 by trophoblast was effectively inhibited by sodium furegrelate (30), a selective TXA 2 synthase inhibitor ( Fig. 2A) . Trophoblasts cultured in the presence of sodium furegrelate showed enhanced levels of hCG at 48 and 72 h, compared with vehicle-treated control cells. Moreover, the effect of the TX synthase inhibitor was concentration dependent (Fig. 2B) . To support our findings, we also examined the effect of SQ 29, 548, a selective TXA 2 receptor antagonist (31-33), and found that media levels of hCG at 72 h were significantly higher in cultures exposed to the antagonist compared with vehicle-treated controls (Fig. 2C) . Although maximum TXA 2 levels were present in cultured trophoblast in the first 12 h, we chose 48 and 72 h time points to estimate media hCG levels because biochemical differentiation can be determined in cultures grown Ͼ24 h (2). These results indicate that endogenous production of TX hinders biochemical differentiation of cultured trophoblasts.
We determined the effect of TXA 2 on morphologic differentiation of primary trophoblasts using syncytium formation as a marker for differentiation. Qualitative assessment of trophoblast cell morphology indicated that Ͼ90% of the nuclei remained as cytotrophoblasts after TXA 2 exposure. In contrast, approximately 50% of the cells exhibited syncytial morphology in control cultures by 72 h (Fig. 3A) . The number of 
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syncytia at 24, 48, and 72 h was significantly less in cells treated with TXA 2 when compared with control cells (Fig. 4A) . These results were reproduced in serum-containing media (data not shown). Taken together, our results indicate that TXA 2 hinders morphologic differentiation of primary trophoblasts. TXA 2 enhances trophoblast apoptosis. TXA 2 induces apoptosis in several cell types (34, 35). We also noted that addition of TXA 2 to the culture yielded a lower cell number by 72 h. We therefore hypothesized that TXA 2 induced apoptosis in cultured trophoblasts. Using TUNEL staining, we observed a significantly higher apoptotic index in cells exposed to TXA 2 , compared with control (Figs. 3B and 4B) . We confirmed these results using morphologic criteria of apoptosis for cells cultured with or without TXA 2 (data not shown). These results were reproduced in serum-containing media. These findings indicate that TXA 2 enhances apoptosis in cultured trophoblasts.
Because p53 mediates diverse apoptotic stimuli (36, 37), we examined the affects of TXA 2 on p53 expression. Using densitometry we found that TXA 2 enhanced the expression of p53 by 2.5-fold compared with control. We observed peak p53 expression between 1 and 2 h after exposure to TXA 2 (Fig.  5A) , which was undetectable by 48 h of culture. Importantly, the induction of p53 by TXA 2 was concentration dependent, with maximal expression at 30 M TXA 2 (Fig. 5B) . These results suggest that TXA 2 induces apoptosis in trophoblasts through a p53-dependent mechanism.
DISCUSSION
Villous trophoblasts undergo biochemical and morphologic differentiation (38) . This process is regulated in vitro through different pathways (38 -40) . Because prostanoids modulate differentiation, apoptosis, and proliferation of nontrophoblast cells, we examined their influence on trophoblast differentiation. Our analysis focused on nine different prostanoids, based on their known effects in other systems (23-27). Of the prostanoids tested, we found that TXA 2 limits both biochemical and morphologic differentiation of cultured villous trophoblasts derived from term human placentas. Two lines of evidence support this premise. 1) Addition of TXA 2 hinders trophoblast differentiation in culture. 2) Inhibition of endogenous TXA 2 production by cultured trophoblast or antagonizing the binding of endogenous TX to its receptor facilitates hormonal differentiation of trophoblasts. We also confirmed earlier observations that the production of TXA 2 by trophoblasts in vitro is maximal in the first few hours of culture (10, 21), before syncytium formation (2) . These data are supported by the observation that the expression and activity of cyclooxygenase are higher in cytotrophoblast than in syncytiotrophoblast (22). Moreover, syncytiotrophoblasts exhibit a higher expression and activity of PG dehydrogenase (41) , which metabolizes prostanoids to inactive products. Nevertheless, the effect of the TX synthase inhibitor sodium furegrelate or the TXA 2 receptor antagonist SQ 29,548 was demonstrated only after 48 h, because significant synthesis of hCG is observed only after trophoblast differentiation into syncytium (2). 
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We also found that TX enhances trophoblast apoptosis. This was demonstrated using TUNEL staining as well as morphologic criteria for apoptotic cells. The temporal relationship between TX exposure and the enhancement of p53 expression suggests that apoptosis occurs through a p53-dependent mechanism. Moreover, induction of p53 was concentrationdependent, lending further support to our inference. Importantly, TX levels are elevated in the serum (12, 42) and placental villi (8, 11) of women with preeclampsia. Consistent with this observation, the expression of cyclooxygenase-2 (8, 21) and TX synthase (43) are enhanced in placental villi from women with preeclampsia. Because apoptosis is more prevalent in placentas from pregnancies complicated by FGR (7) or preeclampsia (44) , it is possible that TX enhances apoptosis in these pregnancy-related diseases. Whether or not the higher level of TX contributes to other aspects of placental dysfunction observed in these diseases, such as maldevelopment of basal plate arteries (45) , syncytial knots (6), and diminished amino acid transport (46) , remains to be established.
Although trophoblast is normally exposed to marked hypoxia during early embryonic development, intervillous PO 2 in the range of 20 -75 mm Hg is observed in the second half of pregnancy (47, 48) . We have previously shown that exposure of trophoblasts to hypoxia (oxygen saturation of 1 to 2%, PO 2 of Ͻ15 mm Hg) in vitro hinders differentiation (22) and enhances apoptosis (49). Other investigators have described similar results (50 -52) . Hypoxia also up-regulates the expression of cylcooxygenase-2, and increases production of TX by trophoblasts (22). These phenotypic changes in trophoblast differentiation are found in placentas from women with preeclampsia and FGR, in which villous hypoxia is commonly found. The mechanisms that control normal and abnormal trophoblast differentiation are poorly understood. Growth factors (epidermal growth factor and transforming growth factor), cytokines (granulocyte macrophage-colony stimulating factor and colony-stimulating factor), and hCG appear to play an important role in this process (53) . Our studies indicate that TX also regulates trophoblast differentiation and apoptosis, in addition to the role of this prostanoid in regulation of placental blood flow (54, 55) . A similar function of prostanoids, elicited in response to hypoxia, has been demonstrated in several cell types (33, 56 -59). Whether or not the influence of hypoxia on trophoblast differentiation is mediated by enhancement of TX production remains to be established. Nevertheless, the role of TX in placental dysfunction suggests that inhibition of TX signaling may limit placental dysfunction in conditions associated with hypoxic trophoblasts. 
